Expertise in
3
conditions

Dr. Thomas G. Keens

Pediatric Pulmonology | Gastroenterology
Children's Hospital Los Angeles
4650 W Sunset Blvd, 
Los Angeles, CA 
Expertise in
3
conditions
Children's Hospital Los Angeles
4650 W Sunset Blvd, 
Los Angeles, CA 

Overview

Thomas Keens is a Pediatric Pulmonologist and a Gastroenterologist practicing medicine in Los Angeles, California.

Dr. Keens is highly rated in 3 conditions, according to our data. His clinical expertise encompasses Congenital Central Hypoventilation Syndrome, Cystic Fibrosis, Asthma, and Hirschsprung Disease.

He is actively involved in clinical research, co-authoring 69 peer reviewed articles and participating in 7 clinical trials.

Specialties

Pediatric Pulmonology
Gastroenterology

Licenses

Pediatric Pulmonology in CA

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO

Locations

Children's Hospital Los Angeles
4650 W Sunset Blvd, Los Angeles, CA 90027

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

APPLAUD: A Double-Blind, Randomized, Placebo-Controlled, Phase II Study of the Efficacy and Safety of LAU-7b in the Treatment of Cystic Fibrosis in Adults
APPLAUD: A Double-Blind, Randomized, Placebo-Controlled, Phase II Study of the Efficacy and Safety of LAU-7b in the Treatment of Cystic Fibrosis in Adults
Enrollment Status: Completed
Publish Date: October 09, 2024
Intervention Type: Drug
Study Drug: Fenretinide
Study Phase: Phase 2
Prospective Evaluation of a Standardized Approach to Diagnosis (PREDICT) and Treatment (PATIENCE) of Nontuberculous Mycobacteria Disease in Cystic Fibrosis
Prospective Evaluation of a Standardized Approach to Diagnosis (PREDICT) and Treatment (PATIENCE) of Nontuberculous Mycobacteria Disease in Cystic Fibrosis
Enrollment Status: Unknown
Publish Date: April 02, 2024
Prospective Evaluation of a Standardized Approach to Diagnosis (PREDICT) and Treatment (PATIENCE) of Nontuberculous Mycobacteria Disease in Cystic Fibrosis
Prospective Evaluation of a Standardized Approach to Diagnosis (PREDICT) and Treatment (PATIENCE) of Nontuberculous Mycobacteria Disease in Cystic Fibrosis
Enrollment Status: Unknown
Publish Date: April 02, 2024
A Phase 1b/2a, Multi-Center, Double-Blind, Randomized, Placebo-Controlled, Single and Multiple Ascending Dose Study to Evaluate the Safety and Tolerability of AP-PA02 Multi-Phage Therapeutic Candidate for Inhalation in Subjects With Cystic Fibrosis and Chronic Pulmonary Pseudomonas Aeruginosa (Pa) Infection
A Phase 1b/2a, Multi-Center, Double-Blind, Randomized, Placebo-Controlled, Single and Multiple Ascending Dose Study to Evaluate the Safety and Tolerability of AP-PA02 Multi-Phage Therapeutic Candidate for Inhalation in Subjects With Cystic Fibrosis and Chronic Pulmonary Pseudomonas Aeruginosa (Pa) Infection
Enrollment Status: Completed
Publish Date: January 31, 2024
Intervention Type: Other, Biological
Study Drug: AP-PA02 Bacteriophage
Study Phase: Phase 1/Phase 2
A Phase III, Randomized, Double-blind, Placebo-controlled Study of AeroVanc for the Treatment of Persistent Methicillin-resistant Staphylococcus Aureus Lung Infection in Cystic Fibrosis Patients
A Phase III, Randomized, Double-blind, Placebo-controlled Study of AeroVanc for the Treatment of Persistent Methicillin-resistant Staphylococcus Aureus Lung Infection in Cystic Fibrosis Patients
Enrollment Status: Completed
Publish Date: December 16, 2022
Intervention Type: Drug
Study Phase: Phase 3
TEACH Trial: Testing the Effect of Adding CHronic Azithromycin to Inhaled Tobramycin. A Randomized, Placebo-controlled, Double-blinded Trial of Azithromycin 500mg Thrice Weekly in Combination With Inhaled Tobramycin
TEACH Trial: Testing the Effect of Adding CHronic Azithromycin to Inhaled Tobramycin. A Randomized, Placebo-controlled, Double-blinded Trial of Azithromycin 500mg Thrice Weekly in Combination With Inhaled Tobramycin
Enrollment Status: Completed
Publish Date: June 28, 2021
Intervention Type: Drug
Study Phase: Phase 4
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy, Safety, and Tolerability of CTX-4430 Administered Orally Once-Daily for 48 Weeks in Adult Patients With Cystic Fibrosis
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy, Safety, and Tolerability of CTX-4430 Administered Orally Once-Daily for 48 Weeks in Adult Patients With Cystic Fibrosis
Enrollment Status: Completed
Publish Date: September 04, 2019
Intervention Type: Drug
Study Phase: Phase 2
View 6 Less Clinical Trials

69 Total Publications

Prevalence of pulmonary hypertension in children with Prader-Willi Syndrome.
Prevalence of pulmonary hypertension in children with Prader-Willi Syndrome.
Journal: Sleep medicine
Published: April 22, 2026
Similar Doctors
Expertise in
23
conditions
Dr. Norah A. Terrault
Gastroenterology
Expertise in
23
conditions
Dr. Norah A. Terrault
Gastroenterology
Referral may be required

Los Angeles-Gi Liver Clinic

1510 San Pablo St Ste 200, 
Los Angeles, CA 
 (5.5 miles away)
323-442-8894
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Norah Terrault is a Gastroenterologist practicing medicine in Los Angeles, California. Dr. Terrault is highly rated in 23 conditions, according to our data. Her clinical expertise encompasses Hepatitis, Hepatitis C, Hepatitis B, Liver Transplant, and Hepato-Pancreato-Biliary Surgery.

Expertise in
42
conditions
Dr. James L. Buxbaum
Gastroenterology
Expertise in
42
conditions
Dr. James L. Buxbaum
Gastroenterology
Referral may be required

Los Angeles-Gi Liver Clinic

1510 San Pablo St Ste 200, 
Los Angeles, CA 
 (5.5 miles away)
323-442-8894
Languages Spoken:
English
See accepted insurances
Offers Telehealth

James Buxbaum is a Gastroenterologist practicing medicine in Los Angeles, California. Dr. Buxbaum is highly rated in 42 conditions, according to our data. His clinical expertise encompasses Acute Pancreatitis, Hereditary Pancreatitis, Bile Duct Obstruction, Endoscopy, and Lithotripsy.

Expertise in
15
conditions
Dr. Mark A. Pimentel
Gastroenterology
Expertise in
15
conditions
Dr. Mark A. Pimentel
Gastroenterology
Referral may be required

Cedars-Sinai Gastrointestinal (Gi) Motility

8720 Beverly Blvd, 
West Hollywood, CA 
 (5.4 miles away)
310-423-6143
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Mark Pimentel is a Gastroenterologist practicing medicine in West Hollywood, California. Dr. Pimentel is highly rated in 15 conditions, according to our data. His clinical expertise encompasses Irritable Bowel Syndrome (IBS), Small Bowel Bacterial Overgrowth, Diarrhea, Endoscopy, and Appendectomy.

Frequently Asked Questions about Dr. Thomas G. Keens

How do I make an appointment with Dr. Thomas G. Keens?

You can book an appointment with Dr. Thomas G. Keens by calling their office at 323-361-2287. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Thomas G. Keens a top-rated expert for Congenital Central Hypoventilation Syndrome?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Thomas G. Keens is classified as an Elite expert for Congenital Central Hypoventilation Syndrome, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Thomas G. Keens specialize in?

While Dr. Thomas G. Keens is a Pediatric Pulmonology, they have specific expertise in Congenital Central Hypoventilation Syndrome, Cystic Fibrosis, and Asthma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Pediatric Pulmonology.

Does Dr. Thomas G. Keens participate in research or clinical trials?

Yes. Dr. Thomas G. Keens has published 69 articles and abstracts on conditions like Congenital Central Hypoventilation Syndrome. You can view a list of Dr. Thomas G. Keens's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Thomas G. Keens accept my insurance?

Dr. Thomas G. Keens accepts most major insurance plans, including Blue Cross Blue Shield and Blue Shield of California. We recommend calling the office directly at 323-361-2287 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Keens's expertise for a condition
ConditionClose
    View All 8 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile